GlassScriptPhysician profile
Lindsay M Shipman
NPI 1992309165
$1,374.24
in general payments reported to CMS, 2019-2025
13 companies · $1,053 in 2025
The $1,053 reported for 2025 was more than what 81% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $13.09 · 2023: $138 · 2024: $171 · 2025: $1,053.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,250 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,249.66 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $313.77 | 2024-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $282.11 | 2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $236.26 | 2023-2025 | Austedo Xr, Uzedy |
| Alkermes, INC. | $171.74 | 2023-2025 | Lybalvi, Aristada, Vivitrol |
| Abbvie INC. | $99.58 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $50.82 | 2024-2025 | Invega Sustenna, Invega Trinza, Spravato |
| Axsome Therapeutics, INC. | $46.08 | 2024-2025 | Auvelity |
| Neurocrine Biosciences, INC. | $42.85 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.18 | 2025 | Trintellix |
| Indivior INC. | $29.47 | 2025 | Sublocade |
| Vanda Pharmaceuticals INC. | $22.23 | 2024 | Fanapt |
| Sage Therapeutics, LLC | $22.11 | 2025 | Zurzuvae |
| Braeburn INC. | $15.04 | 2025 | Brixadi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsay Shipman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.